HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon

East African Medical Journal

Volumn 74, Issue 8, 1997, Pages 474-477

  Kuaban, C ^a   Bercion, R ^a   Koulla Shiro, S ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

THIOACETAZONE; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICA; AFRICA SOUTH OF THE SAHARA; AGED; ARTICLE; BIOLOGY; CAMEROON; DEMOGRAPHIC FACTORS; DERMATOLOGICAL EFFECTS; DEVELOPING COUNTRY; DISEASES; DRUG COMBINATION; DRUG ERUPTION; DRUG MONITORING; DRUGS--SIDE EFFECTS; FEMALE; FRENCH SPEAKING AFRICA; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTIONS; LUNG TUBERCULOSIS; MALE; MEASUREMENT; METHODOLOGY; MIDDLE AFRICA; MIDDLE AGED; MORTALITY; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; PREVALENCE; PROSPECTIVE STUDY; RESEARCH REPORT; SEX RATIO; STUDIES; TREATMENT; TUBERCULOSIS; VIRAL DISEASES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; BIOLOGY; CAMEROON; DEMOGRAPHIC FACTORS; DERMATOLOGICAL EFFECTS; DEVELOPING COUNTRIES; DISEASES; DRUGS--SIDE EFFECTS; FRENCH SPEAKING AFRICA; HIV INFECTIONS; INFECTIONS; MEASUREMENT; MIDDLE AFRICA; MORTALITY; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; PREVALENCE; PROSPECTIVE STUDIES; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; TREATMENT; TUBERCULOSIS; VIRAL DISEASES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CAMEROON; DRUG ERUPTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; HIV SEROPREVALENCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEX DISTRIBUTION; THIOACETAZONE; TUBERCULOSIS, PULMONARY; URBAN HEALTH;

EID: 0031196106     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Selwyn, P.A., Hartel, D., Lewis, V.A., Schoenbaum, E.E., Vermund, S.H., Klein, R.S., Walker, A.T. and Friedland, G.H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 1989; 320: 345-50.
2. Allen, S., Batungwanayo, J. and Kerlikowske, K. Two year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Amer. Rev. Respir. Dis. 1993; 146:1439-44.
3. De Cock, K.M., Soro, B., Coulibaly, I.M. and Lucas, S.B. Tuberculosis and HIV infection in sub - Saharan Africa. J.Amer. Med. Ass. 1992; 268: 1581-87.
4. Nunn, P., Kibuga, D., Gathua, S., Brindle, R., Imalingat, A., Wasuna, K., Lucas, S., Gilks, C., Omwega, M., Were, J. and McAdam, K. Cutaneous hypersensitivity reactions in HIV1 seropositive patients treated for tuberculosis. Lancet. 1991; 377: 627-30.
5. WHO. Severe hypersensivity reactions among HIV seropositive patients with tuberculosis treated with thiacetazone. Wkly. Epidem. Rep. 1992; 67: 1-3.
6. Wirima, J.J. and Harries, A.D. Stevens-Johnson syndrome during antituberculosis chemotherapy in HIV seropositive patients: report of six cases. East. Afr. Med. J. 1991; 68:64-6.
7. Huet, M., Rist, N., Boube, G. and Potier, D. Etude bacteriologique de la tuberculose au Cameroun. Rev. Tuberc. Pneumol. 1971; 35: 413-26.
8. Toure, M. The situation with regard to Mycobacterium africanum in West Africa. Bull Int. Union Tuberc. 1982; 57: 234-45.
9. Vareldis, B.P., Grosset, J., de Kantor, I., Crofton, J., Laszlo, A., Felten, M., Raviglionne and M.C., Kochi, A. Drug resistant tuberculosis: laboratory issues. Tubercle Lung. Dis. 1994; 75:1-7.
10. Posniak, A.L., McLeod, G.A., Mahari, M., Legg, W. and Weinberg, J. The influence of HIV status on single and multiple drugs reactions to antituberculous therapy in Africa. AIDS. 1992; 6: 809-104.
11. Girling, D.J. Adverse effects of antituberculous drugs. Drugs 1982; 23: 56-74.
12. Garin, B., Di, Constanzo, B., Kassa-Kelembho, E., Legot, B., Guerin, D., Ouapou, F., Vohito, M., Yazipo, D. and Mathiot, C. Role de la tuberculose et de ses formes resistantes dans l'infection a VIH en Republique Centrafricaine. VIIIe Conference Internationale sur le SIDA en Afrique. Marrackech, Decembre 1993 (Abstract TOP 33).
13. Mboussa, J. Tuberculose et infection VIH a l'Hopital General de Brazzaville. Rev. Mal Ke.spir 1989; 6: 155-59.
14. Colebunders, L.R., Ryder, W.R., Nzilambi, N., Dikulu, K., Willame, J.C., Kaboto, M., Bagala, N., Jeugmans, J., Muepu, K., Francis, H.L., Mann, J.M., Quinn, T.C. and Piot, P. HIV infection in patients with tuberculosis in Kinshasa. Zaire. Am. Rev. Respir. Dis. 1989; 139: 1082-85.
15. Report on HIV-1 sentinel surveillance system in Cameroon 1994. Ministry of Public Health Yaounde, Cameroon.
16. Kuaban, C., Koulla-Shiro, S., Afane-Ze, E., Ghipponi, P.M. and Pignon, D. Seroprevalence among patients with tuberculosis in Yaounde-Cameroon. VIIth International Conference on AIDS in Africa: Yaounde, December 1992 (Abstract TP 045).
17. Kuaban, C., Mauclere, P., Louis, J.P., Migliani, R., Ndoumou, A., Trebucq, A. and Rey, J.L. Seroprevalence de l'infection par VIH parmi les patients presentant une tuberculose pulmonaire a Yaounde-Cameroun en 1992. VIIe International sur le SIDA en Afrique. Yaounde, Decembre 1992 (Abstract WP 046).
18. WHO. The HIV/AIDS pandemic. 1993 overview document WHO/ GPA/CNP/EVA/93.1 1993.
19. Luo, C., Chintu, C., Bhat, G., Raviglione, M., Diwan, V., Dupont, H.L. and Zumla, A. Human immunodeficiency virus type I in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thiacetazone free regimen. Tubercle Lung. Dis. 1994; 75:110-5.